NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

TB & Outbreaks Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB & Outbreaks Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Asthma



Study data from University of Delhi update understanding of asthma



June 9th, 2009

"States of Haryana, Karnataka, Maharashtra and Rajasthan, and Chennai (capital of Tamil Nadu State), India. To assess the availability, price and affordability of beclomethasone and salbutamol inhalers in five Indian states using a standardised methodology," scientists in New Delhi, India report.

"Data on the availability and price of two essential medicines for asthma, beclomethasone (50 mu g/dose) and salbutamol (0.1 mg/dose) inhalers, were collated from five medicine price studies on essential medicines. Beclomethasone and salbutamol inhalers were available in 25% and 30% of public facilities in Rajasthan State only. The procurement price for beclomethasone and...


Source: TB & Outbreaks Week (2009-06-09)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login